Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4843652

Clc1ccccc1CNc1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.42
RAB9A P51151 3/20 0.41
GFER P55789 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FABP4 P15090 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
MMP8 P22894 2/20 0.38
MMP13 P45452 2/20 0.38
JAK2 O60674 1/20 0.38
NTRK1 P04629 1/20 0.38
TYK2 P29597 1/20 0.38
KDR P35968 1/20 0.38
JAK3 P52333 1/20 0.38
PTK2 Q05397 1/20 0.38
PTK2B Q14289 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5258292 0.91 RAB9A (0.42) FFAR1RAB9AGFERSMN1; SMN2FABP4
Trifluoroacetic Acid SCHEMBL4844143 0.87 ABL1 (0.49) HDAC3HDAC1HDAC2HDAC6PTK2
Trifluoroacetic Acid SCHEMBL4845670 0.85 FFAR1 (0.42) FFAR1FABP4HDAC1KDR
Trifluoroacetic Acid SCHEMBL4839090 0.85 GPR6 (0.43) FFAR1FABP4HDAC3HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4845402 0.84 MEN1 (0.39) KMT2A
Trifluoroacetic Acid SCHEMBL4843358 0.82 ABL1 (0.44) RAB9ASMN1; SMN2HDAC3HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4843563 0.82 ALDH1A1 (0.41) RAB9ASMN1; SMN2MMP2MMP9MMP8
Trifluoroacetic Acid SCHEMBL5259763 0.82 MMP2 (0.35) FFAR1RAB9ASMN1; SMN2HDAC6MMP2
Trifluoroacetic Acid SCHEMBL4841657 0.81 TAAR1 (0.41) RAB9AHDAC1HDAC6MMP2MMP9
Trifluoroacetic Acid SCHEMBL4838725 0.81 MMP2 (0.34) FFAR1RAB9ASMN1; SMN2HDAC6MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 FFAR1 1301/4885RAB9A 1616/4885GFER 4150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.